or Try an Advanced Search...

    ETF Components for PSIL - AdvisorShares Psychedelics ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    MNMD C -4.50 10.44
    ATAI B -4.72 7.66
    GHRS B -5.11 6.36
    CMPS F -3.11 5.40
    ALKS C -0.72 5.34
    RLMD F -2.46 5.01
    ITCI B -0.78 4.94
    SAGE F 2.24 4.78

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Entheogens Mental Health Psychoactive Drugs Depressive Disorder Drug Development Drugs Hyperactivity Disorder Major Depressive Disorder N Dimethyltryptamine Neurochemistry Neuroscience Psychiatric And Neurological Disorders Psychiatry Schizophrenia Treatment Resistant Depression Adjunctive Therapy Aging Associated Diseases Alcohol Alzheimer's Disease
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care Facilities

    Recent News for AdvisorShares Psychedelics ETF & its Holdings

    Date Stock Title
    Nov 20 SAGE After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
    Nov 20 SAGE Sage slips as Huntington’s Disease therapy fails in mid-stage trial
    Nov 20 SAGE Sage’s string of research failures continues
    Nov 20 SAGE Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease
    Nov 19 RLMD Relmada Therapeutics to Present at Jefferies London Healthcare Conference
    Nov 19 SAGE CNS Drug Development: Same As It Ever Was
    Nov 19 ATAI Oxbridge Re Holdings Among 3 US Penny Stocks To Watch
    Nov 19 ITCI Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
    Nov 18 MNMD MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer
    Nov 15 PSIL No Trippin’: Trump Trade Pushes PSIL, VCAR Higher
    Nov 15 CMPS RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up
    Nov 15 ATAI RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up
    Nov 14 GHRS GH Research GAAP EPS of -$0.23 beats by $0.02
    AdvisorShares Trust - AdvisorShares Psychedelics ETF is an exchange traded fund launched and managed by AdvisorShares Investments, LLC. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across healthcare, pharmaceuticals, biotechnology and life sciences companies focused on plant-based psychedelic medicines as well as other companies with business activities in the psychedelics industry sectors. The fund uses derivatives such as swaps to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. The investment seeks long-term capital appreciation. AdvisorShares Trust - AdvisorShares Psychedelics ETF is domiciled in the United States.
    Exchange Traded Funds Biotechnology Pharmaceutical Advisorshares
    Back to the Main PSIL Page...